Analisis Ketahanan Hidup Tumor Testis Sel Germinal di RS Sardjito Periode 2007-2013

Denny Achmad Prayoga* -  , Indonesia
HR Danarto -  , Indonesia

DOI : 10.33371/ijoc.v10i4.490

ABSTRACT
Objective: To know survival of germ cell testicle tumor at Sardjito hospital who had chemotherapy or radiotherapy and its factor which influenced their survival
Method: From year 2007 until 2013, we collected patients with germ cell testicle tumor at Sardjito hospital who had chemotherapy or radiotherapy. The clinical factor that studied were age, histopathology findings, the TNMS staging, clinical staging, therapy and survival status. We evaluate their survival up to five years after therapy. Correlation between survival status with age, histopathology findings, the TNMS staging, clinical staging,
therapy and prognosis were analyzed using Fisher Exact Test. The Kaplan Meier survival analysis was used to calculate survival of germ cell testicle tumor. Result: There are 23 patient of germ cell testicle tumor whom 21 patients had chemotherapy and 2 patients had radiotherapy. There are no correlation between survival status with age, histopathology findings, the TNMS staging, clinical staging, therapy and prognosis (p>0.05). Based on Kaplan Meier survival analysis, their survival were better on age < 30 years old (p=0.534), seminoma type (p=0.860), had chemotherapy (p=0.599), T3 (p=0.031), Nx (p=0.394), Mx (p=0.781), 51 staging (p=0.623) dan 3rdstadium (p=0.732). Based on risk classification, survival of seminoma with intermediate prognosis were better than seminoma with good prognosis (p=0.631) whereas survival of non seminoma with good prognosis were higher than non seminoma with intermediate or poor prognosis (p=0.014). Conclusion: Germ cell testicle tumor at Sardjito hospital had dominant of seminoma type and had already developed into advanced staged with chemoterapy as therapy. Survival of germ cell testicle tumor were lower than other country. T3 staging and non seminoma with good prognosis could be prognostic factor of germ cell testicle tumor at Sardjito hospital.

ABSTRAK
Objektif: Untuk mengetahui gambaran ketahanan hidup pasien tumor testis jenis sel germinal di RS Sardjito yang dilakukan kemoterapi maupun radioterapi serta faktor-faktor yang mempengaruhi ketahanan hidup tumor testis jenis sel germinal Bahan dan cara: Dari tahun 2007-2013, dilakukan pendataan pasien dengan tumor testis jenis sel germinal di RS Sardjito baik yang dilakukan kemoterapi maupun radioterapi. Data yang dipelajari adalah usia, jenis histopatologi, stadium T, N, M, S, stadium klinis dan status ketahanan hidup. Dilakukan evaluasi ketahanan hidup hingga 5 tahun post terapi. Dilakukan analisa bivariat menggunakan tes Fisher untuk menilai hubungan antara ketahanan hidup dengan faktor-faktor seperti usia, jenis histopatologi, stadium T, N, M, S, stadium klinis, jenis terapi dan prognosis. Digunakan kurva Kaplan Meier untuk menilai gambaran ketahanan hidup pasien tumor testis sel germinal. Hasil: Ada 23 pasien tumor testis jenis sel germinal di RS Sardjito periode 2007-2013 dimana 21 pasien mendapatkan kemoterapi dan 2 pasien mendapatkan radioterapi. Tidak dijumpai hubungan bermakna antara ketahanan hidup pasien tumor buli jenis sel germinal dengan usia, jenis histopatologi, stadium T, N, M, S, stadium klinis dan prognosis
(p>0.05). Berdasarkan kurva Kaplan Meier diketahui ketahanan hidup tumor testis sel germinal lebih baik pada usia < 30 tahun (p=0.534), jenis non seminoma (p=0.860), stadium T3 (p=0.031), Nx (p=0.394), Mx (p=0.781), S1 (p=0.623) dan stadium 3 (p=0.732). Berdasarkan klasifikasi resiko, ketahanan hidup tumor testis jenis seminoma dengan prognosis sedang lebih baik dibandingkan tumor testis jenis seminoma dengan prognosis baik (p=0.631) sedangkan ketahanan hidup jenis non seminoma dengan prognosis baik lebih tinggi dibandingkan tumor testis jenis non seminoma dengan prognosis sedang dan buruk (p=0.014). Kesimpulan: Tumor testis sel germinal di RS Sardjito mayoritas jenis seminoma dan sudah dalam stadium lanjut dengan kemoterapi sebagai sarana terapi. Angka ketahanan hidup tumor testis jenis sel germinal
lebih rendah dibandingkan negara lain. Stadium T3 dan grup non seminoma prognosis baik dapat dijadikan faktor prognostik ketahanan hidup tumor testis sel germinal di RS Sardjito.
Keywords
Survival analysis, germ cell testicle tumor
  1. Manescksa RP, Fitzpatrick JM. Epidemiology of Testicular Cancer. BJUI.
  2. 104 (9 Pt B):1329-1333.
  3. Andayani YD, Safei S. Pattern of Germ Cell Testicular Carinoma in
  4. Dharmais Cancer Hospital Between Januari 2000-December 2004.
  5. Indones J Intern Med. 2008. 1(40):11-13.
  6. Tan GH, Azil M, Shamsul AS, Ho CC, Praveen S, Goh EH, et al.
  7. Clinicopathological Features and Survival of Testicular Tumours in a
  8. Southeast Asian University Hospital: A Ten- Year Review. Asian Pac J Can
  9. Prev.2011. 12(10):2727-39.
  10. Suprabawati TE, Umbas R. Karakteristik dan Faktor-faktor Prediktif pada
  11. Tumor Testis Dewasa di Jakarta. Indon J Cancer. 2007. 3:92-5.
  12. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizaz
  13. K, et al. EAU Guidelines on Testicular Cander: 2011 Update. Eur Urol.
  14. 60(2): 304-319
  15. Nur U, Rachet B, Mitny E, Cooper N, Colehan MP. Survival Analysis:
  16. Survival From Testicular Cancer in England and Wales up to 2001.
  17. British J Cancer. 2008. 99(S1):S80-S82.
  18. Jansen-Heijnen M, Gondos A, Bray F, Hakulinen T, Brewster H, Brenner
  19. H. Clinical Relevance of Conditional Survival of Cancer Patients in
  20. Europe: Age-Spesific Analyses of 13 Cancers. J Clin Onc. 2010. 28(15):
  21. -28.
  22. Kuzgunbay B,Yaycioglu O, Soyupak B, Kayis AA, Ayan S, Yavascaoglu I,
  23. et al. Public Awareness of Testicular Cancer and Self- Examination in
  24. Turkey: A Multicenter Study of Turkish Urooncology Society.Uro
  25. Oncology. 2013. 31(3): 386-391
  26. Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA.
  27. International Trends in the Incidence of Testicular Cancer, 1973-2002.
  28. Cancer Epidemiol Biomarkers Prev. 2010.19(5): 1151-1959.
  29. Sugandi S. Referral Pattern of Urological Malignancy in Indonesia. BJU.
  30. 63(1) :1-3.
  31. Soper MS, Hastings JR, Cosmatos HA, Slezak JM, Wang R, Lodin
  32. K.Observation versus adjuvant radiation or chemotherapy in the
  33. management of stage I seminoma: clinical outcomes and prognostic
  34. factors for relapse in a large US cohort.Am J ClinOncol. 2014 ;37(4):356-9

Full Text:
Article Info
Submitted: 2017-09-19
Published: 2017-09-19
Section: Research Articles
Article Statistics: 173 109